• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

作者信息

Swedberg Karl, Cleland John, Dargie Henry, Drexler Helmut, Follath Ferenc, Komajda Michel, Tavazzi Luigi, Smiseth Otto A, Gavazzi Antonello, Haverich Axel, Hoes Arno, Jaarsma Tiny, Korewicki Jerzy, Lévy Samuel, Linde Cecilia, Lopez-Sendon José-Luis, Nieminen Markku S, Piérard Luc, Remme Willem J

机构信息

Sahlgrenska Academy at the Göteborg University, Department of Medicine, Sahlgrenska University Hospital, Sweden.

出版信息

Eur Heart J. 2005 Jun;26(11):1115-40. doi: 10.1093/eurheartj/ehi204. Epub 2005 May 18.

DOI:10.1093/eurheartj/ehi204
PMID:15901669
Abstract
摘要

相似文献

1
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.慢性心力衰竭诊断和治疗指南：执行摘要（2005年更新）：欧洲心脏病学会慢性心力衰竭诊断和治疗特别工作组
Eur Heart J. 2005 Jun;26(11):1115-40. doi: 10.1093/eurheartj/ehi204. Epub 2005 May 18.
2
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).《2008年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》：欧洲心脏病学会2008年急性和慢性心力衰竭诊断与治疗特别工作组制定。与欧洲心脏病学会心力衰竭协会（HFA）合作编写，并得到欧洲重症医学学会（ESICM）认可。
Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17.
3
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).《2008年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》：欧洲心脏病学会2008年急性和慢性心力衰竭诊断与治疗特别工作组制定。与欧洲心脏病学会心力衰竭协会（HFA）合作编写，并得到欧洲重症监护医学学会（ESICM）认可。
Eur J Heart Fail. 2008 Oct;10(10):933-89. doi: 10.1016/j.ejheart.2008.08.005. Epub 2008 Sep 16.
4
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会（HFA）特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
5
[Guidelines for therapy of chronic heart failure].[慢性心力衰竭治疗指南]
Z Kardiol. 2005 Aug;94(8):488-509. doi: 10.1007/s00392-005-0268-4.
6
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》：欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组编著。与欧洲心脏病学会心力衰竭协会（HFA）合作制定。
Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19.
7
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.急性心力衰竭诊断和治疗指南执行摘要：欧洲心脏病学会急性心力衰竭特别工作组
Eur Heart J. 2005 Feb;26(4):384-416. doi: 10.1093/eurheartj/ehi044. Epub 2005 Jan 28.
8
[Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)].《慢性心力衰竭诊断与治疗指南：执行摘要（2005年更新版）》
Ital Heart J Suppl. 2005 Nov;6(11):735-64.
9
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
10
Heart Failure Society of South Africa (HeFSSA) perspective on the European Society of Cardiology (ESC) 2012 chronic heart failure guideline.南非心力衰竭学会（HeFSSA）对欧洲心脏病学会（ESC）2012 年慢性心力衰竭指南的看法。
S Afr Med J. 2013 Jul 29;103(9 Suppl 2):660-7. doi: 10.7196/samj.7319.

引用本文的文献

1
An AI-Enabled, Patient-Centred Digital Platform for Integrated Chronic Heart Failure Management: Architecture, Validation and Clinical Insights.一个用于综合慢性心力衰竭管理的人工智能驱动、以患者为中心的数字平台：架构、验证与临床见解。
Healthc Technol Lett. 2025 Sep 6;12(1):e70015. doi: 10.1049/htl2.70015. eCollection 2025 Jan-Dec.
2
Assessment of breathlessness: a cardiologist's perspective.呼吸困难的评估：心脏病专家的观点。
Breathe (Sheff). 2025 Jun 17;21(2):240097. doi: 10.1183/20734735.0097-2024. eCollection 2025 Apr.
3
Association between life's essential 8 and risk of heart failure: A prospective community-based study.
生命必需的八项指标与心力衰竭风险之间的关联：一项基于社区的前瞻性研究。
Chin Med J (Engl). 2025 Jun 20;138(12):1496-1498. doi: 10.1097/CM9.0000000000003598. Epub 2025 Apr 16.
4
The role of the control of "life's essential 8" for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study.“生命八要素”控制对高血压患者预防心力衰竭及全因死亡率的作用：开滦队列研究
BMC Public Health. 2025 Apr 8;25(1):1322. doi: 10.1186/s12889-025-22422-y.
5
Clinical and Imaging Markers of Cardiac Function and Brain Health: A Meta-Analysis of Community-Based Studies.心脏功能与脑健康的临床及影像标志物：基于社区研究的荟萃分析
Neurology. 2025 Apr 22;104(8):e213421. doi: 10.1212/WNL.0000000000213421. Epub 2025 Mar 26.
6
Modifiable factors and 10-year and lifetime cardiovascular disease risk in adults with new-onset hypertension: insights from the Kailuan cohort.新发高血压成年人的可改变因素与10年及终生心血管疾病风险：来自开滦队列研究的见解
BMC Med. 2025 Feb 11;23(1):80. doi: 10.1186/s12916-025-03923-4.
7
Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients.甘油三酯葡萄糖指数作为H型高血压患者心力衰竭风险的生物标志物。
Sci Rep. 2025 Feb 9;15(1):4828. doi: 10.1038/s41598-025-89211-w.
8
Blood biomarkers to detect functional impairment in adult patients with repaired tetralogy of Fallot.用于检测法洛四联症修复术后成年患者功能障碍的血液生物标志物。
Int J Cardiol Congenit Heart Dis. 2023 Nov 3;14:100483. doi: 10.1016/j.ijcchd.2023.100483. eCollection 2023 Dec.
9
Extracellular fluid volume as a key indicator in home-care management of chronic heart failure: The role of nutritional and exercise therapy.细胞外液量作为慢性心力衰竭家庭护理管理的关键指标：营养和运动疗法的作用。
Clin Case Rep. 2024 Dec 12;12(12):e9434. doi: 10.1002/ccr3.9434. eCollection 2024 Dec.
10
Potential effects of beta-blockers in HFpEF.β受体阻滞剂在射血分数保留的心力衰竭中的潜在作用。
Heart Fail Rev. 2025 Mar;30(2):357-364. doi: 10.1007/s10741-024-10468-w. Epub 2024 Dec 3.